NCT06787937 Communicating About Nicotine Reduction in Cigarettes
| NCT ID | NCT06787937 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgia State University |
| Condition | Tobacco Products |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,230 participants |
| Start Date | 2025-09-11 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,230 participants in total. It began in 2025-09-11 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.
Eligibility Criteria
Inclusion Criteria: * Age 21+ years * Current smoker (self-report as having smoked 100 cigarettes in their lifetime and currently smoking on 27+ days out of past 30, expired breath carbon monoxide \[CO\] ≥6ppm to assess regular smoking) * Can speak, read, and write in English * Available for period of study * Willing to try novel research cigarettes Exclusion Criteria: * Pregnancy or lactation * Member of the same household as a study subject * Unwilling to use research cigarettes as part of the trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06787937 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Tobacco Products. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06787937 currently recruiting?
Yes, NCT06787937 is actively recruiting participants. Contact the research team at lpopova1@gsu.edu for enrollment information.
Where is the NCT06787937 trial being conducted?
This trial is being conducted at Atlanta, United States, Atlanta, United States.
Who is sponsoring the NCT06787937 clinical trial?
NCT06787937 is sponsored by Georgia State University. The trial plans to enroll 1,230 participants.